Grant A. Williams

1.6k total citations
9 papers, 1.3k citations indexed

About

Grant A. Williams is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Grant A. Williams has authored 9 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Grant A. Williams's work include Estrogen and related hormone effects (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Grant A. Williams is often cited by papers focused on Estrogen and related hormone effects (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Grant A. Williams collaborates with scholars based in United States and China. Grant A. Williams's co-authors include Richard Pazdur, Martin H. Cohen, Rajeshwari Sridhara, Gang Chen, Amna Ibrahim, Sophia Abraham, Richard T. Lostritto, David E. Morse, Chenyi Liang and W. David McGuinn and has published in prestigious journals such as Clinical Cancer Research, Inorganic Chemistry and The Oncologist.

In The Last Decade

Grant A. Williams

9 papers receiving 1.2k citations

Peers

Grant A. Williams

ONCOL

PRM

MB

OC

CR

Philip Bonomi United States

Haruhiko Makino Japan

Axel R. Hanauske Germany

Jinee Rizzo United States

Haitian Quan China

Sophia Abraham United States

Sachdev Thomas United States

Jean Cui United States

Toshimitsu Uenaka Japan

Susan Ashton United Kingdom

Philip Bonomi United States

Grant A. Williams

593 ×0.8

ONCOL

403 ×0.7

PRM

592 ×1.3

MB

91 ×0.6

OC

120 ×1.0

CR

Citations per year, relative to Grant A. Williams Grant A. Williams (= 1×) peers Philip Bonomi

Countries citing papers authored by Grant A. Williams

Since Specialization

Citations

This map shows the geographic impact of Grant A. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant A. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant A. Williams more than expected).

Fields of papers citing papers by Grant A. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant A. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant A. Williams. The network helps show where Grant A. Williams may publish in the future.

Co-authorship network of co-authors of Grant A. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Grant A. Williams. A scholar is included among the top collaborators of Grant A. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant A. Williams. Grant A. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Williams, Grant A., et al.. (2020). Synthesis and Characterization of Cu(II) and Mixed-Valence Cu(I)Cu(II) Clusters Supported by Pyridylamide Ligands. Inorganic Chemistry. 59(8). 5433–5446. 45 indexed citations

2.

Cohen, Martin H., Grant A. Williams, Rajeshwari Sridhara, et al.. (2004). United States Food and Drug Administration Drug Approval Summary. Clinical Cancer Research. 10(4). 1212–1218. 415 indexed citations

3.

Trepicchio, William L., Grant A. Williams, David M. Essayan, et al.. (2004). Pharmacogenomic Data Submissions to the FDA: Clinical Case Studies. Pharmacogenomics. 5(5). 519–524. 15 indexed citations

4.

Ibrahim, Amna, Steven Hirschfeld, Martin H. Cohen, et al.. (2004). FDA Drug Approval Summaries: Oxaliplatin. The Oncologist. 9(1). 8–12. 140 indexed citations

5.

Cohen, Martin H., Grant A. Williams, Rajeshwari Sridhara, Gang Chen, & Richard Pazdur. (2003). FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets. The Oncologist. 8(4). 303–306. 465 indexed citations

6.

Cohen, Martin H., Ramzi Dagher, Donna Griebel, et al.. (2002). U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic Acid. The Oncologist. 7(5). 393–400. 42 indexed citations

7.

Bross, Peter, Martin H. Cohen, Grant A. Williams, & Richard Pazdur. (2002). FDA Drug Approval Summaries: Fulvestrant. The Oncologist. 7(6). 477–480. 62 indexed citations

8.

Cohen, Martin H., Steven Hirschfeld, Susan Flamm Honig, et al.. (2001). Drug Approval Summaries: Arsenic Trioxide, Tamoxifen Citrate, Anastrazole, Paclitaxel, Bexarotene. The Oncologist. 6(1). 4–11. 87 indexed citations

9.

Williams, Grant A. & Sidney P. Kent. (1981). Specific Identification of Hemoglobin and Myoglobin in Renal Tubular Casts by the Fluorescent Antibody Technic on Fixed Embedded Tissues. American Journal of Clinical Pathology. 75(5). 726–730. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact